Peter V Danenberg
Overview
Explore the profile of Peter V Danenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishiba T, Hoffmann A, Usher J, Elshimali Y, Sturdevant T, Dang M, et al.
Biochem Biophys Res Commun
. 2018 Apr;
500(3):621-625.
PMID: 29679564
Background: Precision medicine and prediction of therapeutic response requires monitoring potential biomarkers before and after treatment. Liquid biopsies provide noninvasive prognostic markers such as circulating tumor DNA and RNA. Circulating...
2.
Danenberg P, Gustavsson B, Johnston P, Lindberg P, Moser R, Odin E, et al.
Crit Rev Oncol Hematol
. 2016 Sep;
106:118-31.
PMID: 27637357
Folates have been used with cytotoxic agents for decades and today they are used in hundreds of thousands of patients annually. Folate metabolism is complex. In the treatment of cancer...
3.
Wilson P, Danenberg P, Johnston P, Lenz H, Ladner R
Nat Rev Clin Oncol
. 2014 Apr;
11(5):282-98.
PMID: 24732946
Over the past 60 years, chemotherapeutic agents that target thymidylate biosynthesis and the enzyme thymidylate synthase (TS) have remained among the most-successful drugs used in the treatment of cancer. Fluoropyrimidines,...
4.
Jensen L, Rasmussen A, Byriel L, Kuramochi H, Cruger D, Lindebjerg J, et al.
Cell Oncol (Dordr)
. 2013 Sep;
36(5):411-9.
PMID: 24027018
Background: In colorectal cancer MLH1 deficiency causes microsatellite instability, which is relevant for the patient's prognosis and treatment, and its putative heredity. Dysfunction of MLH1 is caused by sporadic gene...
5.
Hoffmann A, Goekkurt E, Danenberg P, Lehmann S, Ehninger G, Aust D, et al.
PLoS One
. 2013 May;
8(5):e64186.
PMID: 23704979
Background: Cholangiocarcinoma remains to be a tumor with very few treatment choices and limited prognosis. In this study, we sought to determine the prognostic role of fms-related tyrosine kinase 1/vascular...
6.
Grimminger P, Maus M, Schneider P, Metzger R, Holscher A, Sugita H, et al.
Lung Cancer
. 2012 Aug;
78(1):87-91.
PMID: 22884253
Introduction: The aim of this study was to investigate the relevance of mRNA expression and DNA methylation of GST-PI in tumor and non-tumor lung tissue from NSCLC patients in terms...
7.
Gandara D, Grimminger P, Mack P, Lara Jr P, Li T, Danenberg P, et al.
J Thorac Oncol
. 2010 Oct;
5(12):1933-8.
PMID: 20975603
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mutations in the epidermal growth factor receptor (EGFR) show improved efficacy from EGFR tyrosine kinase inhibitors. Some clinical...
8.
Grimminger P, Schneider P, Metzger R, Vallbohmer D, Holscher A, Danenberg P, et al.
Clin Lung Cancer
. 2010 Sep;
11(5):328-34.
PMID: 20837458
Background: Thymidylate synthase (TS), thymidine phosphorylase (TP), and dihydropyrimidine dehydrogenase (DPD) are key enzymes in the 5-fluorouracil (5-FU) pathway. The aim of this study was to investigate the mRNA expression...
9.
Grimminger C, Danenberg P
Eur Arch Otorhinolaryngol
. 2010 Sep;
268(1):5-16.
PMID: 20827554
Oropharyngeal squamous cell carcinomas (OSCC) constitute about 5% of all cancers in the western world and the incidence and mortality rates of this tumor have shown little improvement over the...
10.
Hoffmann A, Wild P, Leicht C, Bertz S, Danenberg K, Danenberg P, et al.
Neoplasia
. 2010 Aug;
12(8):628-36.
PMID: 20689757
Purpose: The role of adjuvant chemotherapy in patients with locally advanced bladder cancer still remains to be defined. We hypothesized that assessing the gene expression of the chemotherapy response modifiers...